Medicare Enrolled
Dr. Darlene Gaynor Krupnick, DO
Urology Physician · Wynnewood, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gaynor Krupnick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaynor Krupnick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gaynor Krupnick
Dr. Darlene Gaynor Krupnick is an urology physician in Wynnewood, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gaynor Krupnick performed 5,198 Medicare services across 1,869 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gaynor Krupnick received a total of $13,443 from 29 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gaynor Krupnick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in PA
$13,443 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,198
Medicare services
Top 9% in PA for urology physician
1,869
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~274 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,800 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
592 | $99 | $296 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
467 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
237 | $9 | $66 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
184 | $127 | $358 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
139 | $53 | $85 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
136 | $67 | $207 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
88 | $66 | $117 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
82 | $62 | $600 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $144 | $316 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
49 | $325 | $1,200 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
46 | $130 | $550 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
39 | $6 | $169 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
36 | $45 | $175 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
34 | $29 | $437 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
32 | $325 | $830 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
32 | $167 | $366 |
| Urethral sling procedure for female incontinence A surgical procedure that creates a supportive sling around the urethra to help control urinary leakage in women. |
23 | $588 | $1,422 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
20 | $169 | $1,500 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $140 | $1,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $106 | $215 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
19 | $69 | $900 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $151 | $472 |
| Insertion of temporary bladder tube | 15 | $36 | $118 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
58.4% medium
40.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,443
Total received (2018-2024)
Avg $1,920/year across 7 years
Top 11% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,965 (59.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,478 (40.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,645
2023
$1,556
2022
$614
2021
$669
2020
$250
2019
$8,408
2018
$302
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$398
ABBVIE INC.
$377
Cook Medical LLC
$239
Bayer Healthcare Pharmaceuticals Inc.
$160
Ferring Pharmaceuticals Inc.
$146
Boston Scientific Corporation
$91
Janssen Biotech, Inc.
$50
Sumitomo Pharma America, Inc.
$32
Merck Sharp & Dohme LLC
$31
Novartis Pharmaceuticals Corporation
$31
Teleflex LLC
$24
Tolmar, Inc.
$23
BIOPROTECT MEDICAL, INC.
$22
Telix Pharmaceuticals
$22
Top 3 companies account for 61.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$6,059
Medtronic USA, Inc.
$1,986
Axonics, Inc.
$1,270
Dendreon Pharmaceuticals LLC
$738
Boston Scientific Corporation
$484
ABBVIE INC.
$377
Bayer Healthcare Pharmaceuticals Inc.
$370
Medtronic, Inc.
$352
Ferring Pharmaceuticals Inc.
$334
Cook Medical LLC
$319
Janssen Biotech, Inc.
$224
Janssen Scientific Affairs, LLC
$212
NeoTract Inc.
$120
Bayer HealthCare Pharmaceuticals Inc.
$115
Ethicon US, LLC
$93
Sumitomo Pharma America, Inc.
$59
Tolmar, Inc.
$51
Merck Sharp & Dohme LLC
$31
Novartis Pharmaceuticals Corporation
$31
Coloplast Corp
$27
Teleflex LLC
$24
ConvaTec Inc.
$23
ACCORD HEALTHCARE, INC.
$23
Allergan, Inc.
$22
BIOPROTECT MEDICAL, INC.
$22
Telix Pharmaceuticals
$22
UroGen Pharma, Inc.
$22
180 Medical, Inc.
$18
Astellas Pharma Global Development
$14
Top 3 companies account for 69.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · Axonics · Axonics r-SNM System · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · CAMCEVI · COOK · Cook Medical Urology · ELIGARD · ERLEADA · FIRMAGON · GEMTESA · GENERAL THERAPIES · GENTLECATH · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHO 150 · LithoVue · MYRBETRIQ · Nubeqa · ORGOVYX · Obtryx System - Curved · PLUVICTO · PROVENGE · SOLESTA · Upsylon · UroLift · VISTASEAL · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Urology physicians within 10 mi
299
Per 100K population
34.7
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gaynor Krupnick is a clinical cardiology specialist, with above-average Medicare volume (top 9% in PA), with speaking/promotional industry engagement in the top 11% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gaynor Krupnick experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Gaynor Krupnick performed 2,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaynor Krupnick receive payments from pharmaceutical companies?
Yes. Dr. Gaynor Krupnick received a total of $13,443 from 29 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaynor Krupnick's costs compare to other urology physicians in Wynnewood?
Dr. Gaynor Krupnick's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaynor Krupnick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wynnewood
Browse urology physicians in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology